Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
psilocybin
Biotech
Data on psilocybin in anorexia point Compass to new opportunity
40% of subjects in the small study experienced clinically significant reductions in eating disorder psychopathology after a single dose of psilocybin.
Nick Paul Taylor
May 3, 2022 8:33am
Relieving depression with LSD-like drugs without hallucinations
Jan 31, 2022 3:30pm
Psilocybin shows promise in rat models of alcohol use disorder
Nov 18, 2021 9:40am